Potential Benefits: Significant weight loss (mean 1015% body weight reduction in clinical trials at 2.4 mg weekly dose) when combined with lifestyle modifications [1] [5]
Studies have shown that the NLRP3 inflammasome is also involved in other skin diseases, such as psoriasis, urticaria, and bullous pemphigoid (179)
2) Meno zucchero, pi volume: i cibi troppo raffinati (merendine, bibite) silenziano il Glp-1
The site of injection (abdomen, thigh, or upper arm) can affect the rate of subcutaneous absorption
No, GLP-1 receptor agonists should not replace statins for cholesterol management
Daniel Drucker [Biomarker April 2023] To date, the adverse event profile of GLP-1R agonists is characterized by relatively mild gastrointestinal (GI) side effects, such as nausea, vomiting, and diarrhea